BETA BLOCKER

Beta Blocker Adverse Events Reported to the FDA Over Time

How are Beta Blocker adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Beta Blocker, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Beta Blocker is flagged as the suspect drug causing the adverse event.

Most Common Beta Blocker Adverse Events Reported to the FDA

What are the most common Beta Blocker adverse events reported to the FDA?

Completed Suicide	110 (16.44%)
Death	26 (3.89%)
Poisoning	26 (3.89%)
Drug Toxicity	23 (3.44%)
Cardiac Arrest	18 (2.69%)
Bradycardia	14 (2.09%)
Multiple Drug Overdose	14 (2.09%)
Respiratory Arrest	13 (1.94%)
Drug Interaction	12 (1.79%)
Loss Of Consciousness	10 (1.49%)
Heart Rate Decreased	9 (1.35%)
	Show More
Intentional Drug Misuse	9 (1.35%)
Hypotension	8 (1.2%)
Syncope	8 (1.2%)
Unresponsive To Stimuli	8 (1.2%)
Atrioventricular Block First Degree	7 (1.05%)
Diarrhoea	7 (1.05%)
Haematuria	7 (1.05%)
Abdominal Pain Upper	6 (.9%)
Malaise	6 (.9%)
Multiple Drug Overdose Intentional	6 (.9%)
Ventricular Extrasystoles	6 (.9%)
Agitation	5 (.75%)
Dizziness Postural	5 (.75%)
Expired Drug Administered	5 (.75%)
Fatigue	5 (.75%)
Hypertension	5 (.75%)
Pain	5 (.75%)
Cardiac Failure	4 (.6%)
Cardio-respiratory Arrest	4 (.6%)
Dizziness	4 (.6%)
Flatulence	4 (.6%)
Overdose	4 (.6%)
Palpitations	4 (.6%)
Tachycardia	4 (.6%)
Atrial Fibrillation	3 (.45%)
Blood Pressure Systolic Increased	3 (.45%)
Cardiac Murmur	3 (.45%)
Chest Pain	3 (.45%)
Drug Abuse	3 (.45%)
Fall	3 (.45%)
Hyperkalaemia	3 (.45%)
Renal Cyst	3 (.45%)
Tremor	3 (.45%)
Acidosis	2 (.3%)
Adverse Drug Reaction	2 (.3%)
Anxiety	2 (.3%)
Apnoea	2 (.3%)
Atrioventricular Block	2 (.3%)
Bladder Trabeculation	2 (.3%)
Blindness	2 (.3%)
Blood Albumin Decreased	2 (.3%)
Blood Creatinine Increased	2 (.3%)
Blood Pressure Decreased	2 (.3%)
Blood Pressure Immeasurable	2 (.3%)
Blood Pressure Inadequately Control...	2 (.3%)
Blood Pressure Increased	2 (.3%)
Cardiac Failure Congestive	2 (.3%)
Clonus	2 (.3%)
Condition Aggravated	2 (.3%)
Convulsion	2 (.3%)
Deep Vein Thrombosis	2 (.3%)
Depressed Level Of Consciousness	2 (.3%)
Depression	2 (.3%)
Disease Recurrence	2 (.3%)
Drug Exposure During Pregnancy	2 (.3%)
Drug Ineffective	2 (.3%)
Dyskinesia	2 (.3%)
Dystonia	2 (.3%)
Electrocardiogram Abnormal	2 (.3%)
Eyelid Oedema	2 (.3%)
Foreign Body Sensation In Eyes	2 (.3%)
General Physical Health Deteriorati...	2 (.3%)
Heart Valve Incompetence	2 (.3%)
Hypothermia	2 (.3%)
Ill-defined Disorder	2 (.3%)
Influenza Like Illness	2 (.3%)
Intraocular Pressure Increased	2 (.3%)
Lethargy	2 (.3%)
Mood Altered	2 (.3%)
Multi-organ Failure	2 (.3%)
Muscle Spasms	2 (.3%)
Muscular Weakness	2 (.3%)
Myoclonus	2 (.3%)
Ocular Hyperaemia	2 (.3%)
Oedema Peripheral	2 (.3%)
Pneumonia Aspiration	2 (.3%)
Prostatic Disorder	2 (.3%)
Prostatic Specific Antigen Increase...	2 (.3%)
Renal Failure Acute	2 (.3%)
Respiratory Disorder	2 (.3%)
Sinus Bradycardia	2 (.3%)
Somnolence	2 (.3%)
Suicide Attempt	2 (.3%)
Therapeutic Agent Toxicity	2 (.3%)
Tricuspid Valve Incompetence	2 (.3%)
Tunnel Vision	2 (.3%)
Vision Blurred	2 (.3%)
Weight Increased	2 (.3%)
Accidental Exposure	1 (.15%)
Ageusia	1 (.15%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Beta Blocker, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Beta Blocker is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Beta Blocker

What are the most common Beta Blocker adverse events reported to the FDA?

Suicidal And Self-injurious Behavio...	112 (16.74%)
Cardiac Arrhythmias	61 (9.12%)
Chemical Injury And Poisoning	53 (7.92%)
Neurological	53 (7.92%)
Medication Errors	32 (4.78%)
Cardiac And Vascular Investigations	27 (4.04%)
Fatal Outcomes	26 (3.89%)
Respiratory	21 (3.14%)
Therapeutic And Nontherapeutic Effe...	19 (2.84%)
Psychiatric	13 (1.94%)
Decreased And Nonspecific Blood Pre...	12 (1.79%)
	Show More
Gastrointestinal Signs	11 (1.64%)
Renal Disorders	8 (1.2%)
Urinary Tract Signs	8 (1.2%)
Anxiety Disorders	7 (1.05%)
Gastrointestinal Motility And Defec...	7 (1.05%)
Heart Failures	7 (1.05%)
Movement Disorders	7 (1.05%)
Cardiac Disorder Signs	5 (.75%)
Cardiac Valve	5 (.75%)
Epidermal And Dermal Conditions	5 (.75%)
Muscle	5 (.75%)
Vascular Hypertensive	5 (.75%)
Electrolyte And Fluid Balance Condi...	4 (.6%)
Hepatobiliary	4 (.6%)
Injuries	4 (.6%)
Myocardial	4 (.6%)
Ocular Infections, Irritations And ...	4 (.6%)
Vision	4 (.6%)
Arteriosclerosis, Stenosis, Vascula...	3 (.45%)
Infections - Pathogen Unspecified	3 (.45%)
Lower Respiratory Tract Disorders	3 (.45%)
Musculoskeletal And Connective Tiss...	3 (.45%)
Physical Examination Topics	3 (.45%)
Renal And Urinary Tract Investigati...	3 (.45%)
Acid-base	2 (.3%)
Appetite And General Nutritional	2 (.3%)
Bladder And Bladder Neck Disorders	2 (.3%)
Body Temperature Conditions	2 (.3%)
Bone And Joint Injuries	2 (.3%)
Congenital And Hereditary	2 (.3%)
Deliria	2 (.3%)
Depressed Mood Disorders	2 (.3%)
Embolism And Thrombosis	2 (.3%)
Fungal Infectious	2 (.3%)
Gastrointestinal Hemorrhages	2 (.3%)
Glucose Metabolism Disorders	2 (.3%)
Immunology And Allergy	2 (.3%)
Maternal Complications Of Labour An...	2 (.3%)
Metabolic, Nutritional And Blood Ga...	2 (.3%)
Mood Disorders	2 (.3%)
Neurological Disorders Of The Eye	2 (.3%)
Neurological, Special Senses And Ps...	2 (.3%)
Neuromuscular	2 (.3%)
Ocular Sensory Symptoms	2 (.3%)
Prostatic Disorders	2 (.3%)
Protein And Chemistry Analyses	2 (.3%)
Seizures	2 (.3%)
Skin Appendage Conditions	2 (.3%)
Water, Electrolyte And Mineral	2 (.3%)
Allergic Conditions	1 (.15%)
Anemias Nonhemolytic And Marrow Dep...	1 (.15%)
Angiedema And Urticaria	1 (.15%)
Cardiac And Vascular Disorders Cong...	1 (.15%)
Coagulopathies And Bleeding Diathes...	1 (.15%)
Fetal Complications	1 (.15%)
Gastrointestinal Tract Disorders Co...	1 (.15%)
Gastrointestinal Vascular Condition...	1 (.15%)
Hematology Investigations	1 (.15%)
Hepatic And Hepatobiliary	1 (.15%)
Increased Intracranial Pressure And...	1 (.15%)
Inner Ear And Viiith Cranial Nerve	1 (.15%)
Lipid Analyses	1 (.15%)
Male Genital Tract Therapeutic Proc...	1 (.15%)
Mycobacterial Infectious	1 (.15%)
Neonatal And Perinatal Conditions	1 (.15%)
Ocular Neuromuscular	1 (.15%)
Oral Soft Tissue Conditions	1 (.15%)
Pericardial	1 (.15%)
Peripheral Neuropathies	1 (.15%)
Procedural And Device Related Injur...	1 (.15%)
Product Quality Issues	1 (.15%)
Respiratory And Pulmonary Investiga...	1 (.15%)
Respiratory Tract Therapeutic Proce...	1 (.15%)
Sexual Function And Fertility	1 (.15%)
Sleep Disorders	1 (.15%)
Thyroid Gland	1 (.15%)
Tongue Conditions	1 (.15%)
Urolithiases	1 (.15%)
Vascular	1 (.15%)
Vascular Hemorrhagic	1 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Beta Blocker, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Beta Blocker is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.